TheEdgeResearch
Home / Stocks / PTN

Palatin Technologies, Inc. (PTN)

NASDAQ Healthcare Biotechnology
$4.58 ▼ -7.10%
Market Cap
$8.2M
Sector
Healthcare
Industry
Biotechnology
Beta
-0.07
52-Wk Range
4.51-31
CEO
Carl Spana
Country
US
Currency
USD

Palatin Technologies, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Princeton, NJ, US. The stock last traded at $4.58, down 7.10% on the session, giving a market capitalisation of $8.2M. On trailing twelve-month figures it carries a trailing P/E of -0.40, a net margin of -385.4%. Its beta of -0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.40
Price / Sales
1.74
Price / Book
8.87
EV / EBITDA
-0.25
Gross margin
99.0%
Operating margin
-392.2%
Net margin
-385.4%
Return on equity
—
Debt / equity
0.08
Current ratio
1.67
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
25
IPO date
1997-10-15
Headquarters
Princeton, NJ, US
About Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Comparable companies

Palatin Technologies, Inc. is most often compared with the following Healthcare names:

AFMDARAVBPTSEIGRQFRESMTPNOVNNTBLQTTBVBIV
More research on PTN
PTN technical analysis PTN TheEdge Score Compare against peers
Open full interactive analysis & DCF →